The impact of magnetic resonance imaging–detected extramural vascular invasion (mrEMVI) in distant metastasis is well known but its correlation with prevalence of lymph node metastasis is less studied. The aim of this systematic review and meta-analysis was to assess the prevalence of nodal disease in mrEMVI–positive and negative cases in rectal cancer.
Methods:
Following guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses, a systematic literature search in PubMed, Web of Science, Cochrane Library, and EMBase was carried out to identify relevant studies published up to May 2019.
Results:
Our literature search generated 10 studies (863 and 1212 mrEMVI–positive and negative patients, respectively). The two groups (mrEMVI–positive and negative) were significantly different in terms of nodal disease status (odds ratio [OR] 3.15; 95% confidence interval [CI] 2.12–4.67; p < 0.001). The prevalence of nodal disease was 75.90% vs 52.56% in the positive mrEMVI vs negative mrEMVI group, respectively (p < 0.001). The prevalence of positive lymph node in positive mrEMVI patients treated with neoadjuvant/adjuvant chemoradiotherapy (nCRT/CRT) (OR 2.47; 95% CI 1.65–3.69; p < 0.001) was less compared with the patients who underwent surgery alone (OR 6.25; 95% CI 3.74–10.44; p < 0.001).
Conclusion:
The probability of positive lymph nodes in cases of positive mrEMVI is distinctly greater compared with negative cases in rectal cancer. Positive mrEMVI indicates risk of nodal disease prevalence increased by threefold in rectal cancer.
ColomboPEPataniNBibeauF, et al. Clinical impact of lymph node status in rectal cancer. Surg Oncol2011; 20: e227–e233.
2.
HealdRJRyallRD.Recurrence and survival after total mesorectal excision for rectal cancer. Lancet1986; 1: 1479–1482.
3.
BensonABVenookAPAl-HawaryMM, et al. Rectal cancer, version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw2018; 16: 874–901.
4.
Glynne-JonesRWyrwiczLTiretE, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol2018; 29: iv263.
5.
Habr-GamaAPerezRONadalinW, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg2004; 240: 711–718.
6.
SauerRBeckerHHohenbergerW, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med2004; 351: 1731–1740.
7.
BossetJ-FColletteLCalaisG, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med2006; 355: 1114–1123.
8.
OhH-KKangS-BLeeS-M, et al. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study. Ann Surg Oncol2014; 21: 2280–2287.
9.
SmithNJBarbachanoYNormanAR, et al. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg2008; 95: 229–236.
10.
BuggWGAndreouAKBiswasD, et al. The prognostic significance of MRI-detected extramural venous invasion in rectal carcinoma. Clin Radiol2014; 69: 619–623.
11.
SohnBLimJ-SKimH, et al. MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol2015; 25: 1347–1355.
12.
ChandMSwiftRITekkisPP, et al. Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br J Cancer2014; 110: 19–25.
13.
ChandMEvansJSwiftRI, et al. The prognostic significance of postchemoradiotherapy high-resolution MRI and histopathology detected extramural venous invasion in rectal cancer. Ann Surg2015; 261: 473–9.
14.
ChandMBhanguAWotherspoonA, et al. EMVI-positive stage ii rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy. Ann Oncol2014; 25: 858–863.
15.
SiddiquiMRSSimillisCHunterC, et al. A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases. Br J Cancer2017; 116: 1513.
16.
ZhangX-YWangSLiX-T, et al. MRI of extramural venous invasion in locally advanced rectal cancer: relationship to tumor recurrence and overall survival. Radiology2018; 289: 677–685.
17.
TripathiPRaoSXZengMS.Clinical value of MRI-detected extramural venous invasion in rectal cancer. J Dig Dis2017; 18: 2–12.
18.
TripathiPGuoWRaoS, et al. Additional value of MRI-detected EMVI scoring system in rectal cancer: applicability in predicting synchronous metastasis. Tumori2020; 106: 286–294.
19.
TalbotICCRitchieSLeightonM, et al. Invasion of veins by carcinoma of rectum: method of detection, histological features and significance. Histopathology1981; 5: 141–163.
20.
JhaveriKSHosseini-NikHThipphavongS, et al. MRI detection of extramural venous invasion in rectal cancer: correlation with histopathology using elastin stain. Am J Roentgenol2016; 206: 747–755.
21.
PatelUBBrownGMachadoI, et al. MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial. Ann Oncol2017; 28: 344–353.
22.
SchaapDPOguraANederendJ, et al. Prognostic implications of MRI-detected lateral nodal disease and extramural vascular invasion in rectal cancer. Br J Surg2018; 105: 1844–1852.
23.
LiuLLiuMYangZ, et al. Correlation of MRI-detected extramural vascular invasion with regional lymph node metastasis in rectal cancer. Clin Imaging2016; 40: 456–460.
24.
ChenYYangXWenZ, et al. Association between high-resolution MRI-detected extramural vascular invasion and tumour microcirculation estimated by dynamic contrast-enhanced MRI in rectal cancer: preliminary results. BMC Cancer2019; 19: 498.
25.
BhanguAFitzgeraldJEFSlesserA, et al. Prognostic significance of extramural vascular invasion in T4 rectal cancer. Colorectal Dis2013; 15: e665–e671.
26.
BaeJSKimSHHurBY, et al. Prognostic value of MRI in assessing extramural venous invasion in rectal cancer: multi-readers’ diagnostic performance. Eur Radiol2019; 29: 4379–4388.
27.
ShihabOCTaylorFBeesN, et al. Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer. Br J Surg2011; 98: 1798–1804.
28.
LiuLYangLJinE, et al. Effect of gadolinium contrast-enhanced T1-weighted magnetic resonance imaging for detecting extramural venous invasion in rectal cancer. Abdom Radiol2016; 41: 1736–1743.
29.
SunYLiJShenL, et al. Predictive value of MRI-detected extramural vascular invasion in stage T3 rectal cancer patients before neoadjuvant chemoradiation. Diagn Interv Radiol2018; 24: 128–134.
30.
YuJHuangD-YXuH-X, et al. Correlation between magnetic resonance imaging-based evaluation of extramural vascular invasion and prognostic parameters of T3 stage rectal cancer. J Comput Assist Tomogr2016; 40: 537–542.
31.
HahnloserDWolffBGLarsonDW, et al. Immediate radical resection after local excision of rectal cancer: an oncologic compromise?Dis Colon Rectum2005; 48: 429–437.
32.
IchimasaKKudoS-EMiyachiH, et al. Patient gender as a factor associated with lymph node metastasis in T1 colorectal cancer: a systematic review and meta-analysis. Mol Clin Oncol2017; 6: 517–524.
33.
NascimbeniRBurgartLJNivatvongsS, et al. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum2002; 45: 200–206.
34.
EriksenMTWibeAHaffnerJ, et al. Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum2007; 50: 156–167.
35.
YoonWSParkWChoiDH, et al. Importance of the circumferential extent of tumors and clinical lymph node status as prognostic factors after preoperative chemoradiotherapy and surgery in patients with rectal cancer. Tumori2010; 96: 568–576.
36.
LeiboldTShiaJRuoL, et al. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. J Clin Oncol2008; 26: 2106–2111.
37.
SunYChiPLinH, et al. Inferior mesenteric artery lymph node metastasis in rectal cancer treated with neoadjuvant chemoradiotherapy: incidence, prediction and prognostic impact. Eur J Surg Oncol2017; 43: 85–91.
38.
NagasakiTAkiyoshiTFujimotoY, et al. preoperative chemoradiotherapy might improve the prognosis of patients with locally advanced low rectal cancer and lateral pelvic lymph node metastases. World J Surg2017; 41: 876–883.
39.
MorimotoMMiyakuraYLeforAT, et al. Reduction in the size of enlarged pelvic lymph nodes after chemoradiation therapy is associated with fewer lymph node metastases in locally advanced rectal carcinoma. Surg Today2015; 45: 834–840.
40.
GarlandMLVatherRBunkleyN, et al. Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer. Int J Colorectal Dis2014; 29: 301–307.
41.
PolamrajuPHaqueWVermaV, et al. Adjuvant management of pathologic node-positive disease after definitive surgery for clinical T1-2 N0 rectal cancer. Clin Colorectal Cancer2018; 17: e519–e530.
42.
DinauxAMLeijssenLBordeianouLG, et al. Outcomes of persistent lymph node involvement after neoadjuvant therapy for stage III rectal cancer. Surgery2018; 163: 784–788.
43.
ParkIJYouYNSkibberJM, et al. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. Dis Colon Rectum2013; 56: 135–141.
44.
LeeSDKimTHKimDY, et al. Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection. Eur J Surg Oncol2012; 38: 478–483.
45.
ZuoZ-GZhangX-FWangH, et al. Prognostic value of lymph node ratio in locally advanced rectal cancer patients after preoperative chemoradiotherapy followed by total mesorectal excision. Medicine2016; 95: e2988.
46.
AkagiYShirouzuKFujitaS, et al. Benefit of the measurement of mesorectal extension in patients with pT3N1-2 rectal cancer without pre-operative chemoradiotherapy: post-operative treatment strategy. Exp Ther Med2013; 5: 661–666.
47.
HanNYKimMJParkBJ, et al. Location of rectal cancer as determined using rectal magnetic resonance imaging, and its relationship with pulmonary metastasis. Turkish J Gastroenterol2014; 25: 661–668.
